{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:00:05Z","timestamp":1793606405461,"version":"4.5.0"},"reference-count":165,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.heliyon.2024.e28829","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:29:16Z","timestamp":1711499356000},"page":"e28829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Potential therapeutic effects of green tea (Camellia sinensis) in eye diseases, a review"],"prefix":"10.1016","volume":"10","author":[{"given":"Mohadese","family":"Boroughani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Tahmasbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Mahdi","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadkarim","family":"Johari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hashem","family":"Hashempur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9612-0936","authenticated-orcid":false,"given":"Mojtaba","family":"Heydari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.heliyon.2024.e28829_bib1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/bjophthalmol-2017-310333","article-title":"Burden of vision loss associated with eye disease in China 1990-2020: findings from the Global Burden of Disease Study 2015","volume":"102","author":"Wang","year":"2018","journal-title":"Br. J. Ophthalmol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e28829_bib2","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/jamaophthalmol.2022.4716","article-title":"Toward Universal eye health coverage-key outcomes of the world health organization package of eye care interventions: a systematic review","volume":"140","author":"Keel","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28829_bib3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jcjo.2014.08.014","article-title":"Chronic eye disease and the WHO universal eye health global action plan 2014-2019","volume":"49","author":"Gupta","year":"2014","journal-title":"Can. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28829_bib4","first-page":"547","article-title":"Review of image processing and machine learning techniques for eye disease detection and classification","volume":"3","author":"Umesh","year":"2016","journal-title":"Int. Res. J. Eng. Technol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28829_bib5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1530\/EJE-11-0055","article-title":"Quality of life in thyroid eye disease: impact of quality of care","volume":"164","author":"Estcourt","year":"2011","journal-title":"Eur. J. Endocrinol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e28829_bib6","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1167\/iovs.06-0020","article-title":"Impact of impaired vision and eye disease on quality of life in Andhra Pradesh","volume":"47","author":"Nutheti","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.heliyon.2024.e28829_bib7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.55544\/jrasb.1.3.6","article-title":"Bioactive herbal medicine use for eye sight: a meta analysis","volume":"1","author":"Amle","year":"2022","journal-title":"Journal for Research in Applied Sciences and Biotechnology"},{"key":"10.1016\/j.heliyon.2024.e28829_bib8","article-title":"Camellia sinensis (green tea): a review","volume":"6","author":"Namita","year":"2012","journal-title":"Global J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e28829_bib9","first-page":"35","article-title":"Green tea, black tea and semi-fermented tea","author":"Xu","year":"2002","journal-title":"Tea: Bioactivity and therapeutic potential"},{"issue":"8 Pt 1","key":"10.1016\/j.heliyon.2024.e28829_bib10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1753-4887.2007.tb00314.x","article-title":"Mechanisms and effects of green tea on cardiovascular health","volume":"65","author":"Basu","year":"2007","journal-title":"Nutr. Rev."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28829_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jff.2011.08.003","article-title":"Antioxidant and antiviral activities of lipophilic epigallocatechin gallate (EGCG) derivatives","volume":"4","author":"Zhong","year":"2012","journal-title":"J. Funct.Foods"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e28829_bib12","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.3390\/nu4111679","article-title":"Epigallocatechin Gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea","volume":"4","author":"Du","year":"2012","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e28829_bib13","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jnutbio.2015.07.001","article-title":"Effects of EGCG content in green tea extract on pharmacokinetics, oxidative status and expression of inflammatory and apoptotic genes in the rat ocular tissues","volume":"26","author":"Chu","year":"2015","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.heliyon.2024.e28829_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.753955","article-title":"Anti-inflammatory effects of GTE in eye diseases","volume":"8","author":"Li","year":"2021","journal-title":"Front. Nutr."},{"key":"10.1016\/j.heliyon.2024.e28829_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9105261","article-title":"Green tea catechins: their use in treating and preventing infectious diseases","volume":"2018","author":"Reygaert","year":"2018","journal-title":"BioMed Res. Int."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28829_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1749-8546-3-12","article-title":"Green tea (Camellia sinensis) and cancer prevention: a systematic review of randomized trials and epidemiological studies","volume":"3","author":"Liu","year":"2008","journal-title":"Chin. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28829_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4103\/2225-4110.124326","article-title":"Recent scientific studies of a traditional Chinese medicine, tea, on prevention of chronic diseases","volume":"4","author":"Yang","year":"2014","journal-title":"Journal of Traditional and Complementary Medicine"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28829_bib18","first-page":"26","article-title":"Ayurvedic herbs useful in gastrointestinal cancer","volume":"5","author":"Kumari","year":"2017","journal-title":"Journal of Medicinal Plants"},{"key":"10.1016\/j.heliyon.2024.e28829_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.116063","article-title":"Review on potential effects of traditional Chinese medicine on glaucoma","volume":"304","author":"Qi","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.heliyon.2024.e28829_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110852","article-title":"A review of traditional Chinese medicine on treatment of diabetic retinopathy and involved mechanisms","volume":"132","author":"Ai","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e28829_bib21","article-title":"Current advances in mechanisms and treatment of dry eye disease: toward anti-inflammatory and immunomodulatory therapy and traditional Chinese medicine","volume":"8","author":"Ling","year":"2021","journal-title":"Front. Med."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e28829_bib22","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3109\/13880209.2013.777462","article-title":"Herbal medicinal oils in traditional Persian medicine","volume":"51","author":"Hamedi","year":"2013","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.heliyon.2024.e28829_bib23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cbi.2014.12.017","article-title":"Aldose reductase expression as a risk factor for cataract","volume":"234","author":"Snow","year":"2015","journal-title":"Chem. Biol. Interact."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e28829_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/biom10071003","article-title":"Aldose reductase differential inhibitors in green tea","volume":"10","author":"Balestri","year":"2020","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28829_bib25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1006\/fstl.1994.1085","article-title":"Aldose reductase inhibitors from green tea","volume":"27","author":"Murata","year":"1994","journal-title":"LWT - Food Sci. Technol. (Lebensmittel-Wissenschaft -Technol.)"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28829_bib26","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1254\/jjp.85.322","article-title":"Presence of aldose reductase inhibitors in tea leaves","volume":"85","author":"Sakai","year":"2001","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e28829_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/627674","article-title":"Anti-VEGF therapy and the retina: an update","volume":"2015","author":"Tah","year":"2015","journal-title":"Journal of Ophthalmology"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28829_bib28","article-title":"Anti-VEGF therapy for diabetic eye diseases","volume":"6","author":"Bahrami","year":"2017","journal-title":"The Asia-Pacific Journal of Ophthalmology"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28829_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1350-9462(02)00043-5","article-title":"Vascular endothelial growth factors and angiogenesis in eye disease","volume":"22","author":"Witmer","year":"2003","journal-title":"Prog. Retin. Eye Res."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28829_bib30","first-page":"235","article-title":"Anti-vascular endothelial growth factor indications in ocular disease","volume":"59","author":"Cornel","year":"2015","journal-title":"Rom J Ophthalmol"},{"issue":"48","key":"10.1016\/j.heliyon.2024.e28829_bib31","doi-asserted-by":"crossref","first-page":"12866","DOI":"10.1021\/acs.jafc.8b05998","article-title":"Pang CP: metabolomics of green-tea catechins on vascular-endothelial-growth-factor-stimulated human-endothelial-cell survival","volume":"66","author":"Chu","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.heliyon.2024.e28829_bib32","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.biopha.2017.01.161","article-title":"Green tea and its anti-angiogenesis effects","volume":"89","author":"Rashidi","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28829_bib33","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.survophthal.2014.06.002","article-title":"Systematic review of 342 cases of endogenous bacterial endophthalmitis","volume":"59","author":"Jackson","year":"2014","journal-title":"Surv. Ophthalmol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28829_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0420.2007.01006.x","article-title":"Acute bacterial conjunctivitis","volume":"86","author":"H\u00f8vding","year":"2008","journal-title":"Acta Ophthalmol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28829_bib35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jtos.2014.05.005","article-title":"Treatment of blepharitis: recent clinical trials","volume":"12","author":"Pflugfelder","year":"2014","journal-title":"Ocul. Surf."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28829_bib36","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jaim.2017.05.004","article-title":"Development of botanicals to combat antibiotic resistance","volume":"8","author":"Gupta","year":"2017","journal-title":"J. Ayurveda Integr. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28829_bib37","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/mnfr.200600173","article-title":"Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas","volume":"51","author":"Friedman","year":"2007","journal-title":"Mol. Nutr. Food Res."},{"issue":"1\u20133","key":"10.1016\/j.heliyon.2024.e28829_bib38","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0304-4165(03)00007-2","article-title":"(\u2212) Epigallocatechin-3-gallate inhibits gelatinase activity of some bacterial isolates from ocular infection, and limits their invasion through gelatine","volume":"1620","author":"Blanco","year":"2003","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e28829_bib39","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1128\/AAC.49.10.4339-4343.2005","article-title":"Epigallocatechin gallate inhibits biofilm formation by ocular staphylococcal isolates","volume":"49","author":"Blanco","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28829_bib40","first-page":"240","article-title":"Dry eye: an inflammatory ocular disease","volume":"9","author":"Hessen","year":"2014","journal-title":"J. Ophthalmic Vis. Res."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28829_bib41","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.preteyeres.2011.05.002","article-title":"Inflammation in diabetic retinopathy","volume":"30","author":"Tang","year":"2011","journal-title":"Prog. Retin. Eye Res."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28829_bib42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1442-9071.2006.01225.x","article-title":"Biologic therapies for inflammatory eye disease","volume":"34","author":"Lim","year":"2006","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28829_bib43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1142\/S0192415X1550007X","article-title":"Green tea polyphenol epigallocatechin-3-gallate attenuates TNF-\u03b1-induced intercellular adhesion molecule-1 expression and monocyte adhesion to retinal pigment epithelial cells","volume":"43","author":"Thichanpiang","year":"2015","journal-title":"Am. J. Chin. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28829_bib44","first-page":"1","article-title":"Green tea extract attenuates LPS-induced retinal inflammation in rats","volume":"8","author":"Ren","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28829_bib45","first-page":"408","article-title":"Epigallocatechin-3-gallate attenuates lipopolysaccharide-induced inflammation in human retinal endothelial cells","volume":"7","author":"Zhang","year":"2014","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.heliyon.2024.e28829_bib46","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9208489","article-title":"Retinal diseases associated with oxidative stress and the effects of a free radical scavenger (edaravone)","volume":"2017","author":"Masuda","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28829_bib47","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3390\/ijms23031255","article-title":"The pathomechanism, antioxidant biomarkers, and treatment of oxidative stress-related eye diseases","volume":"23","author":"Hsueh","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28829_bib48","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000063881","article-title":"Green tea (Camellia sinensis) protects against selenite-induced oxidative stress in experimental cataractogenesis","volume":"34","author":"Gupta","year":"2002","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.heliyon.2024.e28829_bib49","article-title":"Green tea catechins are potent anti-oxidants that ameliorate sodium iodate-induced retinal degeneration in rats","volume":"6","author":"Yang","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28829_bib50","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/15569527.2021.1879112","article-title":"Epigallocatechin gallate protects the human lens epithelial cell survival against UVB irradiation through AIF\/endo G signalling pathways in vitro","volume":"40","author":"Wu","year":"2021","journal-title":"Cutan. Ocul. Toxicol."},{"issue":"15","key":"10.1016\/j.heliyon.2024.e28829_bib51","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1002\/jsfa.11294","article-title":"Impacts of Camellia sinensis fermentation end-product (black tea) on retinal microvasculature: an updated OCTA analysis","volume":"101","author":"Do\u011fan","year":"2021","journal-title":"J. Sci. Food Agric."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28829_bib52","doi-asserted-by":"crossref","first-page":"747","DOI":"10.18240\/ijo.2022.05.09","article-title":"Green tea-a new perspective of glaucoma prevention","volume":"15","author":"Gasiunas","year":"2022","journal-title":"Int. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28829_bib53","first-page":"Nc05","article-title":"Efficacy of green tea extract for treatment of dry eye and meibomian gland dysfunction; A double-blind randomized controlled clinical trial study","volume":"11","author":"Nejabat","year":"2017","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.heliyon.2024.e28829_bib54","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/231570","article-title":"Regular Chinese green tea consumption is protective for diabetic retinopathy: a clinic-based case-control study","volume":"2015","author":"Ma","year":"2015","journal-title":"J. Diabetes Res."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e28829_bib55","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00417-009-1064-z","article-title":"Effect of epigallocatechin-gallate on inner retinal function in ocular hypertension and glaucoma: a short-term study by pattern electroretinogram","volume":"247","author":"Falsini","year":"2009","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e28829_bib56","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3390\/diagnostics10080589","article-title":"Novel approaches for imaging-based diagnosis of ocular surface disease","volume":"10","author":"Schmidl","year":"2020","journal-title":"Diagnostics"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e28829_bib57","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/bjo.2005.070888","article-title":"Topical ciclosporin in the treatment of ocular surface disorders","volume":"89","author":"Tatlipinar","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.heliyon.2024.e28829_bib58","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2147\/OPTH.S5555","article-title":"Etiology, prevalence, and treatment of dry eye disease","author":"Gayton","year":"2009","journal-title":"Clin. Ophthalmol."},{"issue":"11, Supplement","key":"10.1016\/j.heliyon.2024.e28829_bib59","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ophtha.2017.07.010","article-title":"The pathophysiology of dry eye disease: what we know and future directions for research","volume":"124","author":"Pflugfelder","year":"2017","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28829_bib60","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/ICU.0000000000000569","article-title":"Advances in dry eye disease treatment","volume":"30","author":"O'Neil","year":"2019","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28829_bib61","first-page":"128","article-title":"The potential use of honey in ophthalmology","volume":"69","author":"Majt\u00e1nov\u00e1","year":"2013","journal-title":"Ceska a Slov. Oftalmol.: Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e28829_bib62","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/ICO.0b013e31821c9b5a","article-title":"Therapeutic efficacy of topical epigallocatechin gallate in murine dry eye","volume":"30","author":"Lee","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.heliyon.2024.e28829_bib63","first-page":"533","article-title":"Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells","volume":"17","author":"Cavet","year":"2011","journal-title":"Mol. Vis."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28829_bib64","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/s41433-020-0786-3","article-title":"Pterygium: new insights","volume":"34","author":"Chu","year":"2020","journal-title":"Eye"},{"key":"10.1016\/j.heliyon.2024.e28829_bib65","doi-asserted-by":"crossref","DOI":"10.1177\/25158414211020152","article-title":"Pterygium: an update on pathophysiology, clinical features, and management","volume":"13","author":"Shahraki","year":"2021","journal-title":"Therapeutic Advances in Ophthalmology"},{"issue":"99","key":"10.1016\/j.heliyon.2024.e28829_bib66","first-page":"S5","article-title":"Pterygium: epidemiology prevention and treatment","volume":"30","author":"Singh","year":"2017","journal-title":"Community Eye Health"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28829_bib67","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/bjophthalmol-2017-310288","article-title":"Comparison among adjuvant treatments for primary pterygium: a network meta-analysis","volume":"102","author":"Fonseca","year":"2018","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28829_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103416","article-title":"Pharmacological treatment strategies of pterygium: drugs, biologics, and novel natural products","volume":"28","author":"Baheran","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.heliyon.2024.e28829_bib69","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s10792-016-0358-5","article-title":"Developments and current approaches in the treatment of pterygium","volume":"37","author":"Hac\u0131o\u011flu","year":"2017","journal-title":"Int. Ophthalmol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28829_bib70","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11596-007-0332-6","article-title":"Inhibitory effect of curcumin on proliferation of human pterygium fibroblasts","volume":"27","author":"Zhang","year":"2007","journal-title":"J. Huazhong Univ. Sci. Technol."},{"issue":"41","key":"10.1016\/j.heliyon.2024.e28829_bib71","doi-asserted-by":"crossref","first-page":"12209","DOI":"10.1021\/acs.jafc.1c04422","article-title":"Green tea catechins attenuate human primary pterygium cell survival and migration via modulation of ERK p42\/p44 and p38 pathways","volume":"69","author":"Yang","year":"2021","journal-title":"J. Agric. Food Chem."},{"issue":"30","key":"10.1016\/j.heliyon.2024.e28829_bib72","first-page":"21","article-title":"Corneal ulcer: diagnosis and management","volume":"12","author":"Garg","year":"1999","journal-title":"Community Eye Health"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e28829_bib73","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1136\/bjo.2008.151167","article-title":"Epidemiological characteristics, predisposing factors and microbiological profiles of infectious corneal ulcers: the Portsmouth corneal ulcer study","volume":"93","author":"Ibrahim","year":"2009","journal-title":"Br. J. Ophthalmol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e28829_bib74","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/ICO.0b013e318199fa77","article-title":"Practice patterns in the management of fungal corneal ulcers","volume":"28","author":"Loh","year":"2009","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28829_bib75","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/bjo.84.4.378","article-title":"Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers","volume":"84","author":"Gangopadhyay","year":"2000","journal-title":"Br. J. Ophthalmol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e28829_bib76","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1167\/iovs.19-27306","article-title":"Inhibition by epigallocatechin gallate of IL-1\u2013induced urokinase-type plasminogen activator expression and collagen degradation by corneal fibroblasts","volume":"60","author":"Sugioka","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28829_bib77","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: an anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Surv. Ophthalmol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28829_bib78","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","article-title":"Ocular neovascularization: an epidemiologic review","volume":"43","author":"Lee","year":"1998","journal-title":"Surv. Ophthalmol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28829_bib79","first-page":"444","article-title":"Corneal neovascularization and biological therapy","volume":"8","author":"Voiculescu","year":"2015","journal-title":"J Med Life"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28829_bib80","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.mehy.2010.09.020","article-title":"(-)-Epigallocatechin 3-gallate (EGCG) at the ocular surface inhibits corneal neovascularization","volume":"76","author":"S\u00e1nchez-Huerta","year":"2011","journal-title":"Med. Hypotheses"},{"issue":"13","key":"10.1016\/j.heliyon.2024.e28829_bib81","first-page":"225","article-title":"The diagnosis and treatment of glaucoma","volume":"117","author":"Schuster","year":"2020","journal-title":"Dtsch Arztebl Int"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28829_bib82","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1442-9071.2012.02773.x","article-title":"Definition of glaucoma: clinical and experimental concepts","volume":"40","author":"Casson","year":"2012","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"R1","key":"10.1016\/j.heliyon.2024.e28829_bib83","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1093\/hmg\/ddx184","article-title":"Genetics of glaucoma","volume":"26","author":"Wiggs","year":"2017","journal-title":"Hum. Mol. Genet."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e28829_bib84","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/ajhp\/62.7.691","article-title":"Glaucoma and its treatment: a review","volume":"62","author":"Lee","year":"2005","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28829_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/etm.2021.10669","article-title":"Neuroprotective role of epigallocatechin-3-gallate in acute glaucoma via the nuclear factor-\u03baB signalling pathway","volume":"22","author":"Zhang","year":"2021","journal-title":"Exp. Ther. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28829_bib86","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.preteyeres.2011.11.002","article-title":"The molecular basis of retinal ganglion cell death in glaucoma","volume":"31","author":"Almasieh","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.heliyon.2024.e28829_bib87","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neulet.2015.06.002","article-title":"Neuroprotective effect of epigallocatechin-3-gallate in a mouse model of chronic glaucoma","volume":"600","author":"Shen","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.heliyon.2024.e28829_bib88","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8407206","article-title":"Green tea extract ameliorates ischemia-induced retinal ganglion cell degeneration in rats","volume":"2019","author":"Yang","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e28829_bib89","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMra0804630","article-title":"Primary open-angle glaucoma","volume":"360","author":"Kwon","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2024.e28829_bib90","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7435754","article-title":"Epigallocatechin-3-Gallate protects trabecular meshwork cells from endoplasmic reticulum stress","volume":"2022","author":"Zhou","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28829_bib91","doi-asserted-by":"crossref","first-page":"747","DOI":"10.18240\/ijo.2022.05.09","article-title":"Green tea\u2014a new perspective of glaucoma prevention","volume":"15","author":"Gasiunas","year":"2022","journal-title":"Int. J. Ophthalmol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e28829_bib92","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1111\/imj.14215","article-title":"The use of biologic agents in the management of uveitis","volume":"49","author":"Trivedi","year":"2019","journal-title":"Intern. Med. J."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28829_bib93","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/09273948.2016.1196713","article-title":"A focus on the epidemiology of uveitis","volume":"26","author":"Tsirouki","year":"2018","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e28829_bib94","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.4103\/ijo.IJO_816_20","article-title":"Drug-induced uveitis: a review","volume":"68","author":"Agarwal","year":"2020","journal-title":"Indian J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28829_bib95","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.berh.2016.07.005","article-title":"Advancements in the management of uveitis","volume":"30","author":"Schwartzman","year":"2016","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.heliyon.2024.e28829_bib96","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6683411","article-title":"Research progress on the mechanism of natural product ingredients in the treatment of uveitis","volume":"2021","author":"Li","year":"2021","journal-title":"Journal of Immunology Research"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e28829_bib97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103995","article-title":"Green tea extract treatment alleviates ocular inflammation in a rat model of endotoxin-induced uveitis","volume":"9","author":"Qin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e28829_bib98","first-page":"1566","article-title":"Systemic and ocular anti-inflammatory mechanisms of green tea extract on endotoxin-induced ocular inflammation","author":"Chu","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28829_bib99","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1038\/s41598-019-38868-1","article-title":"Green tea catechins alleviate autoimmune symptoms and visual impairment in a murine model for human chronic intraocular inflammation by inhibiting Th17-associated pro-inflammatory gene expression","volume":"9","author":"Li","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28829_bib100","doi-asserted-by":"crossref","first-page":"151","DOI":"10.12816\/0042978","article-title":"Cataracts pathophysiology and managements","volume":"70","author":"Alshamrani","year":"2018","journal-title":"The Egyptian Journal of Hospital Medicine"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28829_bib101","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4103\/0301-4738.121141","article-title":"Etiopathogenesis of cataract: an appraisal","volume":"62","author":"Gupta","year":"2014","journal-title":"Indian J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28829_bib102","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/10715762.2013.777155","article-title":"Antioxidants and cataract","volume":"47","author":"Thiagarajan","year":"2013","journal-title":"Free Radic. Res."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28829_bib103","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/dmrr.1075","article-title":"Diabetic cataracts: mechanisms and management","volume":"26","author":"Obrosova","year":"2010","journal-title":"Diabetes\/metabolism research and reviews"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28829_bib104","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4239\/wjd.v10.i3.140","article-title":"Cataract in diabetes mellitus","volume":"10","author":"Kiziltoprak","year":"2019","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.heliyon.2024.e28829_bib105","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/608751","article-title":"Diabetic cataract\u2014pathogenesis, epidemiology and treatment","volume":"2010","author":"Pollreisz","year":"2010","journal-title":"Journal of ophthalmology"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28829_bib106","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2478\/v10102-011-0013-y","article-title":"Natural flavonoids as potential multifunctional agents in prevention of diabetic cataract","volume":"4","author":"Stefek","year":"2011","journal-title":"Interdiscipl. Toxicol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e28829_bib107","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1021\/jf048052l","article-title":"Black and green teas equally inhibit diabetic cataracts in a streptozotocin-induced rat model of diabetes","volume":"53","author":"Vinson","year":"2005","journal-title":"J. Agric. Food Chem."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28829_bib108","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1074\/jbc.M308203200","article-title":"Amyloid fibril formation by lens crystallin proteins and its implications for cataract formation","volume":"279","author":"Meehan","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28829_bib109","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.exer.2008.10.011","article-title":"Genetics of crystallins: cataract and beyond","volume":"88","author":"Graw","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.heliyon.2024.e28829_bib110","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.saa.2017.11.036","article-title":"Probing the inhibitory potency of epigallocatechin gallate against human \u03b3B-crystallin aggregation: spectroscopic, microscopic and simulation studies","volume":"192","author":"Chaudhury","year":"2018","journal-title":"Spectrochim. Acta Mol. Biomol. Spectrosc."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e28829_bib111","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1080\/02713683.2017.1324628","article-title":"Effect of green tea polyphenol epigallocatechin-3-gallate on the aggregation of \u03b1a(66-80) peptide, a major fragment of \u03b1A-crystallin involved in cataract development","volume":"42","author":"Kumar","year":"2017","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.heliyon.2024.e28829_bib112","first-page":"217","article-title":"Epigallocatechin gallate protects against oxidative stress-induced mitochondria-dependent apoptosis in human lens epithelial cells","volume":"14","author":"Yao","year":"2008","journal-title":"Mol. Vis."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28829_bib113","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000209665","article-title":"Novel drug delivery systems for retinal diseases","volume":"41","author":"Lee","year":"2009","journal-title":"Ophthalmic Res."},{"issue":"46","key":"10.1016\/j.heliyon.2024.e28829_bib114","first-page":"19","article-title":"Retinal diseases and vision 2020","volume":"16","author":"Yorston","year":"2003","journal-title":"Community Eye Health"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e28829_bib115","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/nn0901-877","article-title":"The fundamental plan of the retina","volume":"4","author":"Masland","year":"2001","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28829_bib116","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12035-008-8045-9","article-title":"Photoreceptor cell death mechanisms in inherited retinal degeneration","volume":"38","author":"Sancho-Pelluz","year":"2008","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28829_bib117","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41572-021-00265-2","article-title":"Age-related macular degeneration","volume":"7","author":"Fleckenstein","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28829_bib118","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/path.4266","article-title":"Mechanisms of age\u2010related macular degeneration and therapeutic opportunities","volume":"232","author":"van Lookeren Campagne","year":"2014","journal-title":"J. Pathol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28829_bib119","first-page":"473","article-title":"Age-related macular degeneration","volume":"105","author":"Thomas","year":"2021","journal-title":"Med. Clin."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e28829_bib120","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.4103\/1673-5374.284978","article-title":"Medicinal plants and natural products as neuroprotective agents in age-related macular degeneration","volume":"15","author":"Bosch-Morell","year":"2020","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.heliyon.2024.e28829_bib121","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ijbiomac.2018.04.011","article-title":"A polysaccharide from green tea (Camellia sinensis L.) protects human retinal endothelial cells against hydrogen peroxide-induced oxidative injury and apoptosis","volume":"115","author":"Yan","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e28829_bib122","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3109\/02713683.2014.885532","article-title":"Epigallocatechin gallate (EGCG) prevents H2O2-induced oxidative stress in primary rat retinal pigment epithelial cells","volume":"39","author":"Cia","year":"2014","journal-title":"Curr. Eye Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28829_bib123","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2006.09.067","article-title":"Oxidative-induced retinal degeneration is attenuated by epigallocatechin gallate","volume":"1124","author":"Zhang","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.heliyon.2024.e28829_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109606","article-title":"Prodrug of epigallocatechin-3-gallate alleviates choroidal neovascularization via down-regulating HIF-1\u03b1\/VEGF\/VEGFR2 pathway and M1 type macrophage\/microglia polarization","volume":"121","author":"Xu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e28829_bib125","first-page":"171","article-title":"Intraperitoneal injection of (\u2212)-Epigallocatechin-3-gallate protects against light-induced photoreceptor degeneration in the mouse retina","volume":"23","author":"Qi","year":"2017","journal-title":"Mol. Vis."},{"key":"10.1016\/j.heliyon.2024.e28829_bib126","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.3389\/fphar.2018.01280","article-title":"Oxidative stress in age-related macular degeneration: nrf2 as therapeutic target","volume":"9","author":"Bellezza","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2024.e28829_bib127","first-page":"33","article-title":"Long-term exposure to solar ultraviolet radiation as a risk factor for age-related macular degeneration","volume":"31","author":"Plestina-Borjan","year":"2007","journal-title":"Coll. Antropol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28829_bib128","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.bbrc.2013.07.097","article-title":"Epigallocatechin-gallate (EGCG) regulates autophagy in human retinal pigment epithelial cells: a potential role for reducing UVB light-induced retinal damage","volume":"438","author":"Li","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2024.e28829_bib129","first-page":"2528","article-title":"Protective effects of (-)-epigallocatechin gallate on UVA-induced damage in ARPE19 cells","volume":"14","author":"Chan","year":"2008","journal-title":"Mol. Vis."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28829_bib130","first-page":"54","article-title":"EGCG protects against UVB-induced apoptosis via oxidative stress and the JNK1\/c-Jun pathway in ARPE19 cells","volume":"5","author":"Cao","year":"2012","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.heliyon.2024.e28829_bib131","article-title":"Pathophysiology of diabetic retinopathy","volume":"2013","author":"Tarr","year":"2013","journal-title":"Int. Sch. Res. Notices"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28829_bib132","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S2213-8587(13)70112-8","article-title":"Diabetes: a 21st century challenge","volume":"2","author":"Zimmet","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e28829_bib133","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/14712598.2018.1545836","article-title":"Diabetic retinopathy: a complex pathophysiology requiring novel therapeutic strategies","volume":"18","author":"Whitehead","year":"2018","journal-title":"Expet Opin. Biol. Ther."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28829_bib134","first-page":"75","article-title":"Diabetic retinopathy: early diagnosis and effective treatment","volume":"107","author":"Kollias","year":"2010","journal-title":"Dtsch Arztebl Int"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e28829_bib135","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.3390\/molecules23071519","article-title":"Phytochemicals: target-based therapeutic strategies for diabetic retinopathy","volume":"23","author":"Parveen","year":"2018","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28829_bib136","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00125-010-1994-3","article-title":"Epicatechin blocks pro-nerve growth factor (proNGF)-mediated retinal neurodegeneration via inhibition of p75 neurotrophin receptor expression in a rat model of diabetes [corrected]","volume":"54","author":"Al-Gayyar","year":"2011","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28829_bib137","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15027874","article-title":"Epigallocatechin-3-gallate protects retinal vascular endothelial cells from high glucose stress in vitro via the MAPK\/ERK-VEGF pathway","volume":"15","author":"Zhang","year":"2016","journal-title":"Genet. Mol. Res."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28829_bib138","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.yexcr.2019.04.014","article-title":"Epigallocatechin-3-gallate stimulates autophagy and reduces apoptosis levels in retinal M\u00fcller cells under high-glucose conditions","volume":"380","author":"Wang","year":"2019","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28829_bib139","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000330051","article-title":"Green tea prevents hyperglycemia-induced retinal oxidative stress and inflammation in streptozotocin-induced diabetic rats","volume":"47","author":"Kumar","year":"2012","journal-title":"Ophthalmic Res."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28829_bib140","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1167\/iovs.12-10647","article-title":"Green tea is neuroprotective in diabetic retinopathy","volume":"54","author":"Silva","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e28829_bib141","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.optm.2008.01.026","article-title":"Review and update: current treatment trends for patients with retinitis pigmentosa","volume":"80","author":"Shintani","year":"2009","journal-title":"Optometry - Journal of the American Optometric Association"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28829_bib142","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/APO.0000000000000227","article-title":"Retinitis pigmentosa: progress and perspective","volume":"5","author":"Zhang","year":"2016","journal-title":"The Asia-Pacific Journal of Ophthalmology"},{"key":"10.1016\/j.heliyon.2024.e28829_bib143","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/421269","article-title":"Retinitis pigmentosa treatment with western medicine and traditional Chinese medicine therapies","volume":"2015","author":"Xu","year":"2015","journal-title":"J Ophthalmol"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e28829_bib144","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00417-014-2702-7","article-title":"Green tea extract suppresses N-methyl-N-nitrosourea-induced photoreceptor apoptosis in Sprague-Dawley rats","volume":"252","author":"Emoto","year":"2014","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e28829_bib145","doi-asserted-by":"crossref","DOI":"10.3390\/antiox9080718","article-title":"Epigallocatechin gallate slows retinal degeneration, reduces oxidative damage, and modifies circadian rhythms in P23H rats","volume":"9","author":"Perdices","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.heliyon.2024.e28829_bib146","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.850757","article-title":"Recent developments of nanostructures for the ocular delivery of natural compounds","volume":"10","author":"Razavi","year":"2022","journal-title":"Front. Chem."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e28829_bib147","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3109\/03639045.2012.736515","article-title":"Recent advances in ocular drug delivery","volume":"39","author":"Achouri","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.heliyon.2024.e28829_bib148","doi-asserted-by":"crossref","first-page":"7251","DOI":"10.2147\/IJN.S173198","article-title":"Gelatin-epigallocatechin gallate nanoparticles with hyaluronic acid decoration as eye drops can treat rabbit dry-eye syndrome effectively via inflammatory relief","volume":"13","author":"Huang","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.heliyon.2024.e28829_bib149","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jconrel.2019.04.016","article-title":"Catechin solubilization by spontaneous hydrogen bonding with poly(ethylene glycol) for dry eye therapeutics","volume":"307","author":"Shim","year":"2019","journal-title":"J. Contr. Release"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28829_bib150","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12050404","article-title":"Topical application of hyaluronic acid-RGD peptide-coated gelatin\/epigallocatechin-3 gallate (EGCG) nanoparticles inhibits corneal neovascularization via inhibition of VEGF production","volume":"12","author":"Miyagawa","year":"2020","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28829_bib151","doi-asserted-by":"crossref","first-page":"606","DOI":"10.4103\/0253-7613.190766","article-title":"VigiAccess: promoting public access to VigiBase","volume":"48","author":"Shankar","year":"2016","journal-title":"Indian J. Pharmacol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28829_bib152","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.fct.2008.01.052","article-title":"Corneal tattoo with tea infusion","volume":"46","author":"Kuo","year":"2008","journal-title":"Food Chem. Toxicol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28829_bib153","first-page":"152","article-title":"Corneal staining and hot black tea compresses","volume":"19","author":"Achiron","year":"2017","journal-title":"Isr. Med. Assoc. J."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28829_bib154","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2165\/00002018-200831060-00003","article-title":"Safety of green tea extracts : a systematic review by the US Pharmacopeia","volume":"31","author":"Sarma","year":"2008","journal-title":"Drug Saf."},{"key":"10.1016\/j.heliyon.2024.e28829_bib155","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.yrtph.2018.03.019","article-title":"The safety of green tea and green tea extract consumption in adults - results of a systematic review","volume":"95","author":"Hu","year":"2018","journal-title":"Regul. Toxicol. Pharmacol. : RTP (Regul. Toxicol. Pharmacol.)"},{"issue":"13","key":"10.1016\/j.heliyon.2024.e28829_bib156","article-title":"Green tea extract as a multiple compound is the most potent anti-inflammatory agents in endotoxin-induced uveitis","volume":"55","author":"Qin","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e28829_bib157","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1039\/C6MB00256K","article-title":"Protection of human \u03b3B-crystallin from UV-induced damage by epigallocatechin gallate: spectroscopic and docking studies","volume":"12","author":"Chaudhury","year":"2016","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.heliyon.2024.e28829_bib158","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijbiomac.2015.03.040","article-title":"EGCG prevents tryptophan oxidation of cataractous ocular lens human \u03b3-crystallin in presence of H2O2","volume":"77","author":"Chaudhury","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28829_bib159","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3164\/jcbn.2007006","article-title":"Effects of green tea fractions on oxygen-induced retinal neovascularization in the neonatal rat","volume":"41","author":"Saito","year":"2007","journal-title":"J. Clin. Biochem. Nutr."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28829_bib160","first-page":"594","article-title":"Catechin weakens diabetic retinopathy by inhibiting the expression of NF-\u03baB signaling pathway-mediated inflammatory factors","volume":"48","author":"Wang","year":"2018","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2024.e28829_bib161","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijpharm.2018.10.004","article-title":"A Poloxamer-407 modified liposome encapsulating epigallocatechin-3-gallate in the presence of magnesium: characterization and protective effect against oxidative damage","volume":"552","author":"Minnelli","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28829_bib162","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1167\/iovs.16-20843","article-title":"Therapeutic efficacy of nanocomplex of poly(ethylene glycol) and catechin for dry eye disease in a mouse model","volume":"58","author":"Lee","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.heliyon.2024.e28829_bib163","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jconrel.2019.04.016","article-title":"Catechin solubilization by spontaneous hydrogen bonding with poly(ethylene glycol) for dry eye therapeutics","volume":"307","author":"Shim","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.heliyon.2024.e28829_bib164","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.colsurfb.2014.09.042","article-title":"Physicochemical characterization of epigallocatechin gallate lipid nanoparticles (EGCG-LNs) for ocular instillation","volume":"123","author":"Fangueiro","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28829_bib165","doi-asserted-by":"crossref","first-page":"9380","DOI":"10.1038\/s41598-017-09913-8","article-title":"Epigallocatechin gallate-loaded gelatin-g-poly(N-isopropylacrylamide) as a new ophthalmic pharmaceutical formulation for topical use in the treatment of dry eye syndrome","volume":"7","author":"Luo","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024048606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024048606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T13:03:55Z","timestamp":1784207035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024048606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":165,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2405844024048606"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28829","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential therapeutic effects of green tea (Camellia sinensis) in eye diseases, a review","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28829","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e28829"}}